Catalina Retamal

Catalina Retamal

Auto-generated profile, based on publicly available information

Catalina Retamal

Dermatology Department, Faculty of Medicine University of Chile Santiago Chile

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2024 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
DHDan Hartmann
Dan Hartmann
CACatalina Retamal Altbir
Catalina Retamal Altbir
FVFernando Valenzuela
Fernando Valenzuela
Excimer light is a subtype of NB-UVB that emits a 308 nm wavelength, and can provide targeted phototherapy treatment. The absorption of 308 nm light by skin cells leads to therapeutic response in various common and ultraviolet-responsive skin diseases, such as psoriasis and vitiligo, and photo-resistant skin diseases such as prurigo nodularis, localized scleroderma, genital lichen sclerosis, and granuloma annulare, cutaneous T-cell lymphomas, among others. Excimer light has few adverse reactions and overall is well tolerated by patients, furthermore, it can be performed in places that are difficult to access. This article aims to explain the therapeutic bases and applications of excimer light in current dermatology.

18 June 2025 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
DHDan Hartmann
Dan Hartmann
CRCatalina Retamal
Catalina Retamal
FVFernando Valenzuela
Fernando Valenzuela
Atopic Dermatitis (AD) is a chronic inflammatory skin disease affecting a significant portion of the global population. While conventional treatments effectively control and manage symptoms, there is a growing need for more personalized and precise approaches for patients. Precision medicine has emerged as a promising therapeutic strategy that tailors treatment to the individual characteristics of each patient. Complementing this, the Treat-to-Target (T2T) strategy sets specific clinical goals and involves continuous monitoring and treatment adjustments based on real-time patient responses and biomarker data. This review aims to explore the latest advancements in precision medicine and the T2T strategy for AD. A comprehensive literature review was conducted to identify the most recent studies and advancements in precision medicine and the T2T strategy for AD. Recent studies highlight the effectiveness of precision medicine in achieving sustained remission and improving the quality of life for patients. The T2T strategy was shown to be effective in preventing exacerbations and adapting treatments based on real-time patient responses and biomarker data. The lack of a consensus on the clinical implementation of precision medicine and T2T, limited longitudinal studies validating long-term outcomes, challenges in stratifying patients due to biomarker heterogeneity, and barriers to integrating emerging diagnostic technologies into routine practice. Precision medicine and the T2T strategy represent significant advancements in the management of AD. These approaches offer the potential for more personalized, effective, and adaptive treatment protocols, leading to improved patient outcomes. Continuous research and development in these areas are essential to fully realize their potential and integrate them into routine clinical practice.

26 February 2025 in Journal of Cutaneous Medicine and Surgery
Verified
Journal Article
Closed access
CRCatalina Retamal
Catalina Retamal
DHDan Hartmann
Dan Hartmann
FVFernando Valenzuela
Fernando Valenzuela
Vitiligo is an acquired depigmentation skin disease caused by the immune-mediated death of melanocytes. It is the most common cause of depigmentation with an estimated worldwide prevalence of 1% but has shown insufficient response to current therapies. The latest research in vitiligo pathogenesis has translated into finding new molecular targets [type I interferon and Janus kinase signal transducers and transcription activators (JAK STAT) pathways], with new therapies generating promising results, such as JAK inhibitors. Other therapeutic strategies include phototherapy, surgical treatment, and complementary options such as micropigmentation, microneedling, and lasers. This review aimed to discuss the mechanisms involved in the development of the disease and the new therapeutic options that have become available, as well as the evidence on complementary therapies. For this purpose, a review of the evidence was conducted using the PubMed database. Based on this review, it was concluded that the progress in understanding the pathophysiology of vitiligo has allowed for the consideration of new molecular targets, with JAK inhibitors showing particular promise in both systemic and topical applications. Nonetheless, further investigation is required to assess the safety of JAK inhibitors and to determine the optimal regimen and dosage for administering these drugs. Complementary treatments should be considered on a case-by-case basis.

2 October 2025 in Cosmetics
Verified
Journal Article
Open access
PDF file
FVFernando Valenzuela
Fernando Valenzuela
DBDaniza Bilicic
Daniza Bilicic
DHDan Hartmann
Dan Hartmann
CRCatalina Retamal
Catalina Retamal
Quality skin has long been a symbol of health and attractiveness, reflecting both genetic and environmental influences. Multiple elements contribute to beautiful skin. This complex topic influences modern dermatological practices and skincare approaches. This article reviews and explores the characteristics that define beautiful skin, integrating physical attributes with the scientific foundations that underpin them. It also delves into the evolutionary significance of skin appearance and the impact of visible skin conditions on social and psychological well-being. Additionally, it reviews advances in dermatological treatments and preventive measures aimed at achieving beautiful skin.

1 November 2025 in International Journal of Dermatology
Verified
Journal Article
Closed access
CRCatalina Retamal
Catalina Retamal
VAValeria Alfaro‐Fierro
Valeria Alfaro‐Fierro
PMPablo Muñoz‐Alvear
Pablo Muñoz‐Alvear
PVPablo Vargas‐Mora
Pablo Vargas‐Mora

16 February 2026 in Anais Brasileiros de Dermatologia (Versão em Português)
Verified
Journal Article
Open access
EBEine Benavides
Eine Benavides
DHDan Hartmann
Dan Hartmann
CRCatalina Retamal
Catalina Retamal
FVFernando Valenzuela
Fernando Valenzuela